Clinical trial
Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High…
NCT00145574 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00145574 |
|---|---|
| Title | Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol |
| Official title | Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Colesevelam HCl Administered to Pediatric Patients With Heterozygous Familial Hypercholesterolemia on a Stable Dose of Statins or Treatment Naive to Lipid-lowering Therapy |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | colesevelam HCl, placebo |
| Enrollment | 194 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 5, 2005 |
| Last update posted | Apr 15, 2010 |
| Countries | Australia, Austria, Canada, Israel, Netherlands, Norway, South Africa, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: